Stocktoria
Disc Medicine, Inc. IRON
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-08-12
Disc Medicine, Inc. statistics & valuation
Market cap$2.9B
P / B3.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -26.3% | -22.0% | -20.8% | -23.4% | -38.9% |
| Return on equity | -28.7% | -24.7% | -22.1% | -26.5% | 56.0% |
| Debt / equity | 0.04× | 0.06× | 0.00× | — | — |
| Current ratio | 21.94 | 21.17 | 17.06 | 8.79 | 6.74 |
Source: SEC EDGAR filings · CIK 0001816736 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.